Loading…
← CockpitCompetitor Analysis › 6407.T CKD CorporationOpen in the cockpit ↗

CKD Corporation6407.TCompetitor analysis, valuation and peers

Japan · JPY·Industrials›Industrial Machinery

Japanese maker of pneumatic components and automation equipment used in factory assembly and packaging lines.

≈ A smaller Japanese Parker Hannifin for pneumaticsMomentum laggard 2
Mkt cap
$1.54B
US dollars, full cap
Free float
75%
of shares outstanding
$/day
$56.2M
20-day average traded
Fwd P/E
10.8×
forward earnings
ROIC−WACC
-3.1 pp
WACC 14.0%
Hurdle
+4 pp
Req g minus delivered
Next earnings
7 days
13 Nov 2026
Close · JPY¥3,627
1D-7.9%
1W-24.3%
1M-39.8%
3M-38.2%
6M-40.0%
YTD+18.5%
1Y+12.1%
ATR %8.8%
52w lowhigh56.5% off high

What CKD does

Japanese maker of pneumatic components and automation equipment used in factory assembly and packaging lines.

Sells standard parts such as cylinders and valves in volume, largely through trading companies and distributors, so orders follow how much manufacturers invest in lines and tooling. Automation equipment and semiconductor cleanroom parts are built to customer specification and sold project by project, so those orders are lumpier.

In one line: A smaller Japanese Parker Hannifin for pneumatics.

Products and services

  • Pneumatic components
  • Automation/inspection equipment
  • Cleanroom equipment for semiconductors

Customers

  • Automakers
  • Electronics manufacturers
  • Semiconductor fabs
  • Food/pharma packagers

Where it sits in the supply chain

  • Capital goods
  • Factory automation
  • Pneumatic valves/cylinders and…

What could go right

  • Factory automation capex
  • Semiconductor fab equipment demand

What could go wrong

  • Auto/electronics capex cycles

Moat: narrow (installed base, process know-how). Long-standing OEM qualification in pneumatics; competes with larger global automation suppliers.

Headquarters: Komaki, Japan · Founded: 1943 · Employees: 4,826

Named competitors

CKD at a glance

Size CKD (6407.T) is a Japan Industrials company (Industrial Machinery) with a market value of $1.54B, the 565th largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥3,627 on 6 Nov 2026.

Performance Over six months the shares fell 40.0%, against -13.1% for the median peer and +1.8% for the Japan market (cap-weighted) — 3rd lowest of 20 in its peer set.

Growth Revenue grew 11.0% over the last twelve months (peer median +10.2%); the operating margin is 14.0% (peer median 8.5%).

Valuation It trades at 10.8× forward earnings against a peer median of 25.0× (3rd cheapest of 16).

Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.1 points below its cost of capital (14.0% WACC).

Next results Next results expected around 13 Nov 2026 (exchange calendar; dates can move).

Relative performance

7510012511 May 202611 Aug 20266 Nov 2026Peer median 846407.T 60
Six months, rebased to 100: CKD against the median of its 20 peers (local-currency closes).

CKD financials

Reported figures in JPY; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥171B¥158B¥156B¥134B¥159B
Revenue growth—+1%+16%-16%—
Gross profit¥51.9B¥45.7B¥44.2B¥37.0B¥45.5B
EBITDA¥30.9B¥26.6B¥25.6B¥19.9B¥27.8B
Net income¥16.8B¥13.6B¥13.5B¥8.34B¥14.8B
Free cash flown/a¥12.2B¥13.5B-¥12.3B-¥7.00M
Capital expendituren/a¥2.91B¥5.99B¥20.6B¥11.8B
Total debt¥33.2B¥34.6B¥35.8B¥37.5B¥18.6B

Quarterly statements and history in the cockpit →

CKD competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-25%0%+25%+50%601882301603HLIO6103603203002645600619603698300171688139300185002164002943603583INRNCROMPTON1651GDWN6407.T6-month return →1-month return →
Up and to the right = strong over both horizons. CKD is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%20×40×601882HLIO6103603203002645603698300171688139300185002943603583INRNCROMPTON16516407.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. CKD is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%601882301603HLIO603203600619300171688139300185INRNCROMPTON1651GDWN6407.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. CKD is the large dot.

CKD competitors and peer comparison

Head to head with its named competitors (6407.T vs 6273.T vs PH vs 6417.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
CKD 6407.T$1.54B-40%+11%14%10.8×12.4%
Smc 6273.T$21.9B-27%+16%24%15.9×16.2%
Parker Hannifin PH$116B+4%+8%22%24.4×19.0%
Sankyo 6417.T$2.68B+16%-23%31%10.2×-18.7%

How CKD compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

CKD against its 20 peers (data as of 6 Nov 2026)
Measure6407.TPeer medianRank in peer set
1-month return-39.8%-7.7%lowest of 21
6-month return-40.0%-13.1%3rd lowest of 20
Distance from 52-week high-56.5%-40.7%5th lowest of 21
Revenue growth (TTM)+11.0%+10.2%11th highest of 21
Operating margin14.0%8.5%4th highest of 21
Forward P/E10.8×25.0×3rd cheapest of 16
Growth the price implies (Req g, 7 yrs)12.4%12.8%7th least demanding of 14
Growth delivered (Del g)+8.1%+10.8%4th lowest of 14
Hurdle (Req g minus delivered)+4.3 pp+2.1 pp6th most demanding of 14
ROIC minus cost of capital-3.1 pp-2.4 pp7th lowest of 21
EV / EBITDA7.6×10.8×3rd cheapest of 8
Net debt / EBITDA-0.3×-0.7×3rd most indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
CKD 6407.TJapan$1.54B-40%+11%14%10.8×12.4%+8.1%
Ningbo Haitian Precision Machinery 601882.SSChina$1.56B-1%+19%11%20.0×12.8%+15.6%
Jirfine Intelligent Equipment 301603.SZChina$1.53B-12%+43%15%n/a28.5%+26.7%
Helios Technologies HLIOUnited States$1.56B-30%+14%13%14.6×11.2%+9.9%
Rokae (Shandong) Robotics 3752.HKHong Kong$1.52Bn/a+105%-5%n/an/an/a
Okuma 6103.TJapan$1.56B-16%+15%9%10.4×n/an/a
Quick Intelligent Equipment 603203.SSChina$1.57B-12%+20%21%39.3×28.7%+15.2%
Jiangsu Huahong Technology Stock 002645.SZChina$1.52B-38%+57%5%20.6×n/an/a
Shanghai Highly (Group) 600619.SSChina$1.57B-33%+3%3%n/a8.6%+13.1%
Changzheng Engineering Technology 603698.SSChina$1.51B-57%-4%7%33.0×n/an/a
Tofflon Science and Technology 300171.SZChina$1.57B+4%-2%6%34.7×8.0%+14.0%
Qingdao Haier Biomedical 688139.SSChina$1.58B+6%+12%9%36.5×20.7%+10.8%
Tongyu Heavy Industry 300185.SZChina$1.59B-17%+6%4%43.7×6.3%+3.1%
Ningbo Donly 002164.SZChina$1.49B+49%+5%5%n/an/an/a
Hunan Yujing Machinery 002943.SZChina$1.60B-42%-36%-23%37.5×n/an/a
Zhejiang Jiecang Linear Motion Technology 603583.SSChina$1.60B-4%+5%8%26.0×n/an/a
Interroll INRN.SWSwitzerland$1.47B-11%+2%13%20.6×1.4%-0.6%
Crompton Greaves Consumer Electricals CROMPTON.NSIndia$1.47B-26%+12%8%23.6×20.5%+11.0%
LU-VE LUVE.MIItaly$1.47B-13%+8%10%25.0×14.5%+8.6%
Precision Tsugami (China) 1651.HKHong Kong$1.62B-35%+24%28%7.7×-13.9%+9.8%
Goodwin GDWN.LUnited Kingdom$1.46B+16%+2%13%n/a47.7%-12.1%

Questions

Who are CKD's main competitors?
Named competitors: SMC Corporation (6273.T), Parker Hannifin (PH), Festo (private or unlisted), Koganei (6417.T). The cockpit's measured peer set (industry) also includes Ningbo Haitian Precision Machinery (601882.SS), Jirfine Intelligent Equipment (301603.SZ), Helios Technologies (HLIO), Rokae (Shandong) Robotics (3752.HK), Okuma (6103.T), Quick Intelligent Equipment (603203.SS).
Is CKD expensive compared with its peers?
On forward p/e it trades at 10.8× against a peer median of 25.0×, 3rd cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has CKD stock performed?
Over six months to 6 Nov 2026 the shares returned -40.0% against -13.1% for the median peer; over one year +12.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.